| Issue |
Title |
File |
| Vol 13, No 7 (2013) |
BIBR 1532 Increases Arsenic Trioxide-mediated Apoptosis in Acute Promyelocytic Leukemia Cells: Therapeutic Potential for APL |
(Eng)
|
|
Kazerani M., Hezave K., Hassani S., Rostami M., Alimoghaddam K., Ghavamzadeh A., Bashash D., H.Ghaffari S., Zaker F.
|
| Vol 25, No 10 (2025) |
Bioactive Products Targeting C-Met As Potential Antitumour Drugs |
(Eng)
|
|
Zhao L., Qian C., Ma X., Wang X.
|
| Vol 11, No 4 (2011) |
Bioactive Sphingolipids in Response to Chemotherapy: A Scope on Leukemias |
(Eng)
|
|
Atakan Ekiz H., Baran Y.
|
| Vol 12, No 10 (2012) |
Bioavailability and Pharmacokinetics of Genistein: Mechanistic Studies on its ADME |
(Eng)
|
|
Yang Z., Kulkarni K., Zhu W., Hu M.
|
| Vol 16, No 11 (2016) |
Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes |
(Eng)
|
|
Ludwig G., Mojić M., Bulatović M., Mijatović S., Maksimović-Ivanić D., Steinborn D., Kaluđerović G.
|
| Vol 13, No 3 (2013) |
Biology and Medicinal Chemistry Approaches Towards Various Apoptosis Inducers |
(Eng)
|
|
K. Vyas V., Chintha C., R. Pandya M.
|
| Vol 24, No 13 (2024) |
Biosynthesis and Anticancer Activity of Genistein Glycoside Derivatives |
(Eng)
|
|
Zheng X., Zhang J., Liu S., Yu Y., Peng Q., Peng Y., Yao X., Peng X., Zhou J.
|
| Vol 12, No 2 (2012) |
Bisphosphonate Anticancer Activity in Multiple Myeloma |
(Eng)
|
|
Terpos E.
|
| Vol 12, No 2 (2012) |
Bisphosphonate Anticancer Activity in Prostate Cancer and Other Genitourinary Cancers |
(Eng)
|
|
Saad F., Mulders P.
|
| Vol 12, No 2 (2012) |
Bisphosphonates and Breast Cancer Prevention |
(Eng)
|
|
T. Chlebowski R., Col N.
|
| Vol 12, No 2 (2012) |
Bisphosphonates in Lung Cancer: Can They Provide Benefits Beyond Prevention of Skeletal Morbidity? |
(Eng)
|
|
Hirsh V.
|
| Vol 15, No 1 (2015) |
Bleomycin Induced Sensitivity to TRAIL/Apo-2L-Mediated Apoptosis in Human Seminomatous Testicular Cancer Cells is Correlated with Upregulation of Death Receptors |
(Eng)
|
|
Timur M., Cort A., Ozdemir E., Sarikcioglu S., Sanlioglu S., Sanlioglu A., Ozben T.
|
| Vol 10, No 8 (2010) |
Blockade of MUC1 Expression by Glycerol Guaiacolate Inhibits Proliferation of Human Breast Cancer Cells |
(Eng)
|
|
Baker C., Smith J., Colon J., Madero-Visbal R., Isley B., Konduri S.
|
| Vol 12, No 5 (2012) |
Boronated Compounds for Imaging Guided BNCT Applications |
(Eng)
|
|
Geninatti-Crich S., Deagostino A., Toppino A., Alberti D., Venturello P., Aime S.
|
| Vol 10, No 4 (2010) |
Boron-Containing Compounds as Preventive and Chemotherapeutic Agents for Cancer |
(Eng)
|
|
I. Scorei R., Popa R.
|
| Vol 12, No 8 (2012) |
Bovine Serum Albumin Significantly Improves the DPPH Free Radical Scavenging Potential of Dietary Polyphenols and Gallic Acids |
(Eng)
|
|
Cao H., Chen X., Yamamoto K.
|
| Vol 11, No 3 (2011) |
BRAF as a Target for Cancer Therapy |
(Eng)
|
|
Dienstmann R., Tabernero J.
|
| Vol 16, No 12 (2016) |
Brain-metastatic Breast Cancer: Clinical Considerations and Pharmacological Approaches |
(Eng)
|
|
Andrade A., Ferruzzi D., Panis C.
|
| Vol 15, No 1 (2015) |
BRCA1 as Target for Breast Cancer Prevention and Therapy |
(Eng)
|
|
Romagnolo A., Romagnolo D., Selmin O.
|
| Vol 13, No 2 (2013) |
BRCA2 Dysfunction Promotes Malignant Transformation of Pancreatic Intraepithelial Neoplasia |
(Eng)
|
|
Wang Q., Liu H., liu T., Shu S., Jiang H., Cheng S., Yuan Y., Yang W., Wang L.
|
| Vol 24, No 3 (2024) |
Bunium persicum Seeds Extract in Combination with Vincristine Mediates Apoptosis in MCF-7 Cells through Regulation of Involved Genes and Proteins Expression |
(Eng)
|
|
Samandari-Bahraseman M.R., Ismaili A., Esmaeili-Mahani S., Ebrahimie E., Loit E.
|
| Vol 12, No 7 (2012) |
Calculation of Molecular Features with Apparent Impact on Both Activity of Mutagens and Activity of Anticancer Agents |
(Eng)
|
|
A. Toropov A., P. Toropova A., Benfenati E., Gini G., Leszczynska D., Leszczynski J.
|
| Vol 11, No 1 (2011) |
Can We Effectively Degrade Microcystins? - Implications on Human Health |
(Eng)
|
|
A. de la Cruz A., G. Antoniou M., Hiskia A., Pelaez M., Song W., E. O'Shea K., He X., D. Dionysiou D.
|
| Vol 13, No 9 (2013) |
Cancer, Aging and Immune Reconstitution |
(Eng)
|
|
Zanussi S., Serraino D., Dolcetti R., Berretta M., Paoli P.
|
| Vol 13, No 5 (2013) |
Cancer Antibody Enhanced Real Time Imaging Cell Probes a Novel Theranostic Tool using Polymer Linked Carbon Nanotubes and Quantum Dots |
(Eng)
|
|
Brakmane G., Madani S.Y., Seifalian A.
|
| Vol 15, No 8 (2015) |
Cancer Chemoprevention by Natural Carotenoids as an Efficient Strategy |
(Eng)
|
|
Bolhassani A.
|
| Vol 11, No 10 (2011) |
Cancer Nanotechnology: Emerging Role of Gold Nanoconjugates |
(Eng)
|
|
A. Kudgus R., Bhattacharya R., Mukherjee P.
|
| Vol 12, No 10 (2012) |
Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets |
(Eng)
|
|
Pratheeshkumar P., Sreekala C., Zhang Z., Budhraja A., Ding S., Son Y., Wang X., Hitron A., Hyun-Jung K., Wang L., Lee J., Shi X.
|
| Vol 25, No 6 (2025) |
Capivasertib: First Approved AKT inhibitor for the Treatment of Patients with Breast Cancer |
(Eng)
|
|
De S.
|
| Vol 23, No 10 (2023) |
Caracasine, An ent-kaurane Diterpene with Proapoptotic and Pro-differentiator Activity in Human Leukaemia Cell Lines |
(Eng)
|
|
Martínez G., Mijares M., Chávez K., Chirinos P., Suárez A., Compagnone R., De Sanctis J.
|
| Vol 23, No 14 (2023) |
Carbon Nanotubes in Breast Cancer Treatment: An Insight into Properties, Functionalization, and Toxicity |
(Eng)
|
|
Srivastava N., Mishra Y., Mishra V., Ranjan A., Tambuwala M.
|
| Vol 13, No 1 (2013) |
Carbon Nanotubes in the Diagnosis and Treatment of Malignant Melanoma |
(Eng)
|
|
Naderi N., Y. Madani S., Ferguson E., Mosahebi A., M. Seifalian A.
|
| Vol 23, No 15 (2023) |
Cardiotoxicity of Targeted Therapies in Children with Haematological Malignancies and Solid Tumors |
(Eng)
|
|
Bangeas A., Tragiannidis A.
|
| Vol 14, No 9 (2014) |
Caspases and ROS - Dependent Mechanism of Action Mediated by Combination of WP 631 and Epothilone B |
(Eng)
|
|
Rogalska A., Bukowska B., Marczak A.
|
| Vol 13, No 6 (2013) |
Castration Resistant Prostate Cancer (CRPC): State of the Art, Perspectives and New Challenges |
(Eng)
|
|
Massari F., Maines F., Modena A., Brunelli M., Bria E., Artibani W., Martignoni G., Tortora G.
|
| Vol 14, No 2 (2014) |
CCL21 and IFNγ Recruit and Activate Tumor Specific T cells in 3D Scaffold Model of Breast Cancer |
(Eng)
|
|
Phan-Lai V., Kievit F., Florczyk S., Wang K., Disis M., Zhang M.
|
| Vol 12, No 9 (2012) |
CCR5 as a Potential Target in Cancer Therapy: Inhibition or Stimulation? |
(Eng)
|
|
Gonzalez-Martin A., Mira E., Manes S.
|
| Vol 25, No 7 (2025) |
CD36 as a Therapeutic Target in Tumor Microenvironment and Lipid Metabolism |
(Eng)
|
|
Li J., Chen J., Yang G., Zhang S., Li P., Ye L.
|
| Vol 25, No 15 (2025) |
CDH1-involved Ubiquitination of SIRT5 Promotes the Entry of Colorectal Cancer Cells into Quiescence and Enhances Cell Stemness |
(Eng)
|
|
Li W., Chen J., Yang J., Zhang B., Wen D., Jiang Z.
|
| Vol 12, No 8 (2012) |
CDK1 Hyperphosphorylation Maintenance Drives the Time-course of G2-M Cell Cycle Arrest after Short Treatment with NAMI-A in Kb Cells |
(Eng)
|
|
Bergamo A., Delfino R., Casarsa C., Sava G.
|
| Vol 13, No 8 (2013) |
Celecoxib Inhibits Helicobacter pylori-induced Invasion of Gastric Cancer Cells Through an Adenine Nucleotide Translocator-Dependent Mechanism |
(Eng)
|
|
Lan C., Yang L., Fan L., Zhang Y., Wang J., Guo G., Wan S., Yang S., Wang R., Fang D.
|
| Vol 10, No 9 (2010) |
Cell Biological Manifestations of Bisdioxopiperazines: Treatment of Human Tumor Cell Lines in Culture |
(Eng)
|
|
Lu D., Lu D., Ding J.
|
| Vol 11, No 7 (2011) |
Cell Contact/Adhesion Proteins Lgl and DFak56: Tumorigenic and Whole-Organism Vital Effects Studied in Drosophila |
(Eng)
|
|
Ya. Weisman N., D. Golubovsky M.
|
| Vol 24, No 1 (2024) |
Cell Death Induced by the Combination of Ephedra sinica Extract and Radiation in HNSCC is Positively Related to BAX and p-MLKL Expression |
(Eng)
|
|
Woo S.R., Noh J.K., Ahn S., Lee M.K., Yu H.S., Min S., Kong M., Lee J.W., Lee Y.C., Ko S., Eun Y.
|
| Vol 13, No 2 (2013) |
Cell Dormancy and Tumor Refractory |
(Eng)
|
|
Yu Y., Zhu Z.
|
| Vol 13, No 4 (2013) |
Cell Survival Signaling in Neuroblastoma |
(Eng)
|
|
L. Megison M., A. Gillory L., A. Beierle E.
|
| Vol 24, No 1 (2024) |
Cellular and DNA Toxicity Study of Triphenyltin Ethyl Phenyl Dithiocarbamate and Triphenyltin Butyl Phenyl Dithiocarbamate on K562, Leukemia Cell Line |
(Eng)
|
|
Hamid A., Rajab N.F., Charmagne Y., Awang N., Jufri N.F., Rasli N.R.
|
| Vol 11, No 2 (2011) |
Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors |
(Eng)
|
|
T. Keir S., W. Dewhirst M., P. Kirkpatrick J., D. Bigner D., Batinic-Haberle I.
|
| Vol 11, No 4 (2011) |
Cellular Uptake and Organ Accumulation of Amphipolar Metallocorroles with Cytoprotective and Cytotoxic Properties |
(Eng)
|
|
Okun Z., Kupershmidt L., B. H. Youdim M., Gross Z.
|
| Vol 11, No 9 (2011) |
Ceramidases in Hematological Malignancies: Senseless or Neglected Target? |
(Eng)
|
|
Fabrias G., Bedia C., Casas J., Luis Abad J., Delgado A.
|
| Vol 12, No 4 (2012) |
Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death |
(Eng)
|
|
Mullen T.D., Obeid L.M.
|
| Vol 11, No 9 (2011) |
Ceramide Transfer Protein and Cancer |
(Eng)
|
|
Scheffer L., Rao Raghavendra P., Ma J., K. Acharya J.
|
| Vol 11, No 9 (2011) |
Ceramide-Based Therapeutics for the Treatment of Cancer |
(Eng)
|
|
M. Barth B., C. Cabot M., Kester M.
|
| Vol 24, No 14 (2024) |
Cerium Oxide Nanoparticles Synthesis using Alhagi Maurorum Leaf Extract and Evaluation of Their Cytotoxic Effect on Breast Cancer Cell Lines and Antibacterial Effects |
(Eng)
|
|
Hosseini S., Khatami M., Asadollahi A., Yaghoobi H.
|
| Vol 24, No 8 (2024) |
Cervical Cancer Therapeutics: An In-depth Significance of Herbal and Chemical Approaches of Nanoparticles |
(Eng)
|
|
Saraswat I., Goel A.
|
| Vol 14, No 7 (2014) |
Chalcone-Coumarin Derivatives as Potential Anti-Cancer Drugs: An in vitro and in vivo Investigation |
(Eng)
|
|
Jamier V., Marut W., Valente S., Chereau C., Chouzenoux S., Nicco C., Lemarechal H., Weill B., Kirsch G., Jacob C., Batteux F.
|
| Vol 24, No 2 (2024) |
Chalcones as Potential Cyclooxygenase-2 Inhibitors: A Review |
(Eng)
|
|
Mahboubi-Rabbani M., Zarei R., Baradaran M., Bayanati M., Zarghi A.
|
| Vol 14, No 9 (2014) |
Chalcones Incorporated Pyrazole Ring Inhibit Proliferation, Cell Cycle Progression, Angiogenesis and Induce Apoptosis of MCF7 Cell Line |
(Eng)
|
|
Mohamed M., Mohamed M., Fathi M., Shouman S., Abdelhamid I.
|
| Vol 13, No 7 (2013) |
Changes in Glutathione, Oxidative Stress and Mitochondrial Membrane Potential in Apoptosis Involving the Anticancer Activity of Cantharidin Isolated from Redheaded Blister Beetles, Epicauta hirticornis |
(Eng)
|
|
Verma A., Prasad S.
|
| Vol 23, No 10 (2023) |
Characterization of Functionalized PLGA Nanoparticles Loaded with Mangiferin and Lupeol, and their Effect on BEAS-2B and HepG2 Cell Lines |
(Eng)
|
|
Fabián R., Mayra H., Manuel Z., Guadalupe S., Alejandro P., Alberto S.
|
| Vol 12, No 5 (2012) |
Chelating Systems for 99mTc/188Re in the Development of Radiolabeled Peptide Pharmaceuticals |
(Eng)
|
|
Bolzati C., Carta D., Salvarese N., Refosco F.
|
| Vol 22, No 10 (2022) |
Chemical Constituents and Antitumor Mechanisms of Artemisia |
(Eng)
|
|
Kamarya Y., Lijie X., Jinyao L.
|
| Vol 23, No 16 (2023) |
Chemical Constituents from the Roots of Jasminum sambac (L.) Ait. and their Cytotoxicity to the Cancer Cell Lines |
(Eng)
|
|
Olatunde O., Yong J., Lu C.
|
| Vol 14, No 2 (2014) |
Chemical Metabolic Inhibitors for the Treatment of Blood-Borne Cancers |
(Eng)
|
|
Villalba M., Lopez-Royuela N., Krzywinska E., Rathore M., Hipskind R., Haouas H., Allende-Vega N.
|
| Vol 11, No 3 (2011) |
Chemical Properties and Mechanisms Determining the Anti-Cancer Action of Garlic-Derived Organic Sulfur Compounds |
(Eng)
|
|
Cerella C., Dicato M., Jacob C., Diederich M.
|
| Vol 14, No 3 (2014) |
Chemically Synthesized Matrix Metalloproteinase and Angiogenesis-inhibiting Peptides as Anticancer Agents |
(Eng)
|
|
Hu J., Yan M., Pu C., Wang J., Van den Steen P., Opdenakker G., Xu H.
|
| Vol 12, No 6 (2012) |
Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents |
(Eng)
|
|
Speck-Planche A., V. Kleandrova V., Luan F., Natalia D. S. Cordeiro M.
|
| Vol 15, No 9 (2015) |
Chemomodulating Effects of Flavonoids in Human Leukemia Cells |
(Eng)
|
|
Sak K., Everaus H.
|
| Vol 12, No 10 (2012) |
Chemoprevention of Breast Cancer by Dietary Compounds |
(Eng)
|
|
S. Vadodkar A., Suman S., Lakshmanaswamy R., Damodaran C.
|
| Vol 13, No 10 (2013) |
Chemoprevention of Skin Cancer: Effect of Lawsonia inermis L. (Henna) Leaf Powder and its Pigment Artifact, Lawsone in the Epstein- Barr Virus Early Antigen Activation Assay and in Two-Stage Mouse Skin Carcinogenesis Models |
(Eng)
|
|
Kapadia G., Rao G., Sridhar R., Ichiishi E., Takasaki M., Suzuki N., Konoshima T., Iida A., Tokuda H.
|
| Vol 12, No 3 (2012) |
Chemotherapeutic Targeting of Cell Death Pathways |
(Eng)
|
|
Mansilla S., Llovera L., Portugal J.
|
| Vol 23, No 11 (2023) |
Chloroform Fraction of Drymaria cordata Linn (CFDC) Suppresses Estradiol Benzoate- Induced Endometrial Hyperplasia |
(Eng)
|
|
Olowofolahan A., Akinjiola O., Olanlokun J., Oyebode O., Aina O., Olorunsogo O.
|
| Vol 12, No 4 (2012) |
Cholesterol, Cardiolipin, and Mitochondria Permeabilisation |
(Eng)
|
|
Lucken-Ardjomande Hasler S.
|
| Vol 25, No 17 (2025) |
Chrysin Exhibits Selective Antiproliferative and Antimigratory Activities in a Wide Range of Human-derived Cervical Cancer Cell Lines |
(Eng)
|
|
de Assis Carvalho A.R., Ferreira Damke G., de Freitas Meirelles L., Pantarotto Souza R., Ratti B., Damke E., Bruschi M., Consolaro M., da Silva V.
|
| Vol 15, No 2 (2015) |
Chrysin Induces Apoptosis in Peripheral Blood Lymphocytes Isolated from Human Chronic Lymphocytic Leukemia |
(Eng)
|
|
Zaric M., Mitrovic M., Nikolic I., Baskic D., Popovic S., Djurdjevic P., Milosavljevic Z., Zelen I.
|
| Vol 10, No 10 (2010) |
Cilengitide: The First Anti-Angiogenic Small Molecule Drug Candidate. Design, Synthesis and Clinical Evaluation |
(Eng)
|
|
Mas-Moruno C., Rechenmacher F., Kessler H.
|
| Vol 13, No 10 (2013) |
Cinnamaldehyde-Induced Apoptosis in Human Hepatoma PLC/PRF/5 Cells Involves the Mitochondrial Death Pathway and is Sensitive to Inhibition by Cyclosporin A and z-VAD-fmk |
(Eng)
|
|
Lin L., Tai C., Chang S., Chen J., Wu S., Lin C.
|
| Vol 23, No 20 (2023) |
CircFAT1 Promotes the Proliferation and Invasion of Malignant Melanoma through miR375-SLC7A11 Signal Axis |
(Eng)
|
|
Lu T., Yang D., Li X.
|
| Vol 16, No 12 (2016) |
Circulating Tumor Cells: A New Window for Diagnosis and Evaluation of Cancer |
(Eng)
|
|
Liu M., Tang M., Li M., Gao F., Shi C., Hou J., Zeng W.
|
| Vol 11, No 8 (2011) |
Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma |
(Eng)
|
|
G. Rainov N., Heidecke V.
|
| Vol 25, No 1 (2025) |
Clinical Efficacy and Safety of CD7-Targeted CAR T Cell Therapy for T-cell Malignancies: A Systematic Review and Meta-analysis |
(Eng)
|
|
Dashti M., Habibi M., Nejati N., Robat-Jazi B., Ahmadpour M., Dokhani N., Nejad A., Karami S., Alinejad E., Malekijoo A., Ghasemzadeh A., Jadidi-Niaragh F.
|
| Vol 11, No 7 (2011) |
Clinical Importance and Potential Use of Small Molecule Inhibitors of Focal Adhesion Kinase |
(Eng)
|
|
Schultze A., Fiedler W.
|
| Vol 12, No 9 (2012) |
Colon Adenocarcinoma Multidrug Resistance Reverted by Euphorbia Diterpenes: Structure-Activity Relationships and Pharmacophore Modeling |
(Eng)
|
|
Reis M., J. Ferreira R., Serly J., Duarte N., M. Madureira A., J. V. A. Santos D., Molnar J., U. Ferreira M.
|
| Vol 13, No 8 (2013) |
Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs |
(Eng)
|
|
Prados J., Melguizo C., Ortiz R., Perazzoli G., Cabeza L., Álvarez P., Rodriguez-Serrano F., Aranega A.
|
| Vol 13, No 9 (2013) |
Colorectal Cancer in Elderly Patients: From Best Supportive Care to Cure |
(Eng)
|
|
Berretta M., Benedetto F., Francia R., Menzo E., Palmeri S., Tirelli U., Paoli P.
|
| Vol 24, No 6 (2024) |
Combination of Ethacrynic Acid and ATRA Triggers Differentiation and/or Apoptosis of Acute Myeloid Leukemia Cells through ROS |
(Eng)
|
|
Cai X., Li L., Xi H., Lu H.
|
| Vol 11, No 5 (2011) |
Combination Therapy for the Treatment of Pancreatic Cancer |
(Eng)
|
|
Greenhalf W., Thomas A.
|
| Vol 10, No 6 (2010) |
Combination Therapy with Arsenic Trioxide for Hematological Malignancies |
(Eng)
|
|
Takahashi S.
|
| Vol 13, No 2 (2013) |
Combinations of Plant Polyphenols & Anti-Cancer Molecules: A Novel Treatment Strategy for Cancer Chemotherapy |
(Eng)
|
|
Mohan A., Narayanan S., Sethuraman S., Maheswari Krishnan U.
|
| Vol 15, No 4 (2015) |
Combined Anticancer Therapies: An Overview of the Latest Applications |
(Eng)
|
|
Piccolo M., Menale C., Crispi S.
|
| Vol 23, No 9 (2023) |
Combined Application of Salinomycin and ATRA Induces Apoptosis and Differentiation of Acute Myeloid Leukemia Cells by Inhibiting WNT/β-Catenin Pathway |
(Eng)
|
|
Xi H., Lu H., Weng X., Sheng Y., Wu J., Li L., Cai X.
|
| Vol 14, No 4 (2014) |
Combining Anti-tumor Alkyl-Phospholipid Analogs and Radiotherapy: Rationale and Clinical Outlook |
(Eng)
|
|
Verheij M., Moolenaar W., Blitterswijk W.
|
| Vol 10, No 5 (2010) |
Compounds from Wild Mushrooms with Antitumor Potential |
(Eng)
|
|
C.F.R. Ferreira I., A. Vaz J., Vasconcelos M.H., Martins A.
|
| Vol 13, No 5 (2013) |
Computational and Functional Analysis of the Androgen Receptor Antagonist Atraric Acid and Its Derivatives |
(Eng)
|
|
Papaioannou M., Soderholm A.A., Hong W., Dai Y., Roediger J., Roell D., Thiele M., Nyronen T.H., Baniahmad A.
|
| Vol 25, No 13 (2025) |
Computational Modelling Strategies for Exploring Triazolopyridazine PIM1 Kinase Inhibitors as Anticancer Agents |
(Eng)
|
|
Walhekar V., Bagul C., Kumar D., Achaiah G., Muthal A., Kulkarni R., Basavarju M.
|
| Vol 12, No 7 (2012) |
Concurrent Administration of Rituximab and CHOP Chemotherapeutic Agents for Outpatients with CD20-positive Lymphoma |
(Eng)
|
|
Yakushijin Y., Tatsukawa T., Yamaguchi T., Egawa T., Hidaka N., Ido K., Suemaru K., Yasukawa M., Araki H.
|
| Vol 13, No 2 (2013) |
Conventional Chemotherapy and Emerging Targeted Therapy for Advanced Adrenocortical Carcinoma |
(Eng)
|
|
Xu Y., Zhu Y.
|
| Vol 11, No 7 (2011) |
Coordinated Expression of Pax-5 and FAK1 in Metastasis |
(Eng)
|
|
Crapoulet N., O'Brien P., J. Ouellette R., A. Robichaud G.
|
| Vol 14, No 1 (2014) |
Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma |
(Eng)
|
|
Yao W., Ko B., Liu T., Liang S., Liu C., Lu Y., Tzean S., Shen T., Liou J.
|
| Vol 14, No 1 (2014) |
Cordycepin Suppresses Integrin/FAK Signaling and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma |
(Eng)
|
|
Yao W., Ko B., Liu T., Liang S., Liu C., Lu Y., Tzean S., Shen T., Liou J.
|
| 201 - 300 of 1242 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 > >> |
